-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Abbott Laboratories, Lowers Price Target to $122

Benzinga·10/22/2026 19:23:10
Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $125 to $122.